Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03324373
Title Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yousef Zakharia
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.